Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
Interventions
Sponsor
Gamida Cell ltd